respiratory diseases

New immunization is the first approved and recommended in the US to prevent severe RSV disease in all infants

Beyfortus proved to be safe and efficacious in trials with infants at varying degrees of risk for RSV infection

Results of the trial using the CM001 inhalable drug formulation are expected in 2024

Mini-lung buds can be cultured and employed for high-throughput analysis of lung tissue infection without interfering variables

First-ever, stable human organoid culture system from lung and nasal tissue helped study SARS-CoV-2 variant transmission

Updates on respiratory syncytial virus (RSV), including diagnostic tools and treatment options

This document updates the previous guide with the latest recommendations regarding new tools for diagnosis

Using DNA as "bait" to detect respiratory viruses with highly accurate results

RSV news includes a new partnership, the launch of a combo test, a campaign to combat surging respiratory infections

Study links more severe RSV with greater damage to cells lining the nose